Loading...
Safety Evaluation of the MiniMed 670G System in Children 7–13 Years of Age with Type 1 Diabetes
Objective: To evaluate the safety of in-home use of the MiniMed™ 670G system with SmartGuard™ technology in children with type 1 diabetes (T1D). Methods: Participants (N = 105, ages 7–13 years, mean age 10.8 ± 1.8 years) were enrolled at nine centers (eight in the United States and one in Israel) an...
Na minha lista:
| Udgivet i: | Diabetes Technol Ther |
|---|---|
| Main Authors: | , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Mary Ann Liebert, Inc., publishers
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6350071/ https://ncbi.nlm.nih.gov/pubmed/30585770 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/dia.2018.0264 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|